Chugai OTC Stock Volatility

CHGCF -  USA Stock  

USD 27.57  0.00  0.00%

Chugai Pharmaceutical secures Sharpe Ratio (or Efficiency) of -0.21, which signifies that the company had -0.21% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Chugai Pharmaceutical exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Chugai Pharmaceutical mean deviation of 0.8182, and Risk Adjusted Performance of (0.28) to double-check the risk estimate we provide.
  
Refresh
Chugai Pharmaceutical OTC Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Chugai daily returns, and it is calculated using variance and standard deviation. We also use Chugai's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Chugai Pharmaceutical volatility.

30 Days Market Risk

Very steady

Chance of Distress

Below Average

30 Days Economic Sensitivity

Moves indifferently to market moves
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Chugai Pharmaceutical can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Chugai Pharmaceutical at lower prices. For example, an investor can purchase Chugai stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Chugai Pharmaceutical's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Chugai Pharmaceutical

0.63NSAVNet Savings LinkPairCorr

Moving against Chugai Pharmaceutical

-0.84MRKMerck CompanyPairCorr
-0.82OXYOccidental Petroleum Corp Potential GrowthPairCorr
-0.8VLOValero Energy CorpPairCorr
-0.79GOGLGolden Ocean GpPairCorr
-0.78XOMExxon Mobil CorpPairCorr
-0.72RMSLRemsleep HoldingsPairCorr
-0.72AZPNAspen Technology Fiscal Year End 10th of August 2022 PairCorr

Chugai Pharmaceutical Market Sensitivity And Downside Risk

Chugai Pharmaceutical's beta coefficient measures the volatility of Chugai otc stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Chugai otc stock's returns against your selected market. In other words, Chugai Pharmaceutical's beta of -0.17 provides an investor with an approximation of how much risk Chugai Pharmaceutical otc stock can potentially add to one of your existing portfolios.
Let's try to break down what Chugai's beta means in this case. As returns on the market increase, returns on owning Chugai Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Chugai Pharmaceutical is likely to outperform the market.
3 Months Beta |Analyze Chugai Pharmaceutical Demand Trend
Check current 90 days Chugai Pharmaceutical correlation with market (DOW)

Chugai Beta

    
  -0.17  
Chugai standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  1.72  
It is essential to understand the difference between upside risk (as represented by Chugai Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Chugai Pharmaceutical stock's daily returns or price. Since the actual investment returns on holding a position in Chugai Pharmaceutical stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Chugai Pharmaceutical.

Chugai Pharmaceutical OTC Stock Volatility Analysis

Volatility refers to the frequency at which Chugai Pharmaceutical stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Chugai Pharmaceutical's price changes. Investors will then calculate the volatility of Chugai Pharmaceutical's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Chugai Pharmaceutical's volatility:

Historical Volatility

This type of stock volatility measures Chugai Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict Chugai Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Chugai Pharmaceutical's current market price. This means that the stock will return to its initially predicted market price.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Developed by Larry Williams, the Weighted Close is the average of Chugai Pharmaceutical high, low and close of a chart with the close values weighted twice. It can be used to smooth an indicator that normally takes only Chugai Pharmaceutical closing price as input.
.

Chugai Pharmaceutical Projected Return Density Against Market

Assuming the 90 days horizon Chugai Pharmaceutical has a beta of -0.1732 suggesting as returns on benchmark increase, returns on holding Chugai Pharmaceutical are expected to decrease at a much lower rate. During the bear market, however, Chugai Pharmaceutical is likely to outperform the market.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chugai Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chugai Pharmaceutical stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chugai stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Chugai Pharmaceutical is significantly underperforming DOW.
 Predicted Return Density 
      Returns 
Chugai Pharmaceutical's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how Chugai Pharmaceutical stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Company's Stock Price Volatility?

Several factors can influence a company's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Chugai Pharmaceutical OTC Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chugai Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chugai Pharmaceutical stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chugai stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Assuming the 90 days horizon the coefficient of variation of Chugai Pharmaceutical is -472.98. The daily returns are distributed with a variance of 2.95 and standard deviation of 1.72. The mean deviation of Chugai Pharmaceutical is currently at 0.85. For similar time horizon, the selected benchmark (DOW) has volatility of 1.36
α
Alpha over DOW
-0.38
β
Beta against DOW-0.17
σ
Overall volatility
1.72
Ir
Information ratio -0.15

Chugai Pharmaceutical OTC Stock Return Volatility

Chugai Pharmaceutical historical daily return volatility represents how much Chugai Pharmaceutical stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The firm shows 1.7186% volatility of returns over 90 . By contrast, DOW inherits 1.3665% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About Chugai Pharmaceutical Volatility

Volatility is a rate at which the price of Chugai Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Chugai Pharmaceutical may increase or decrease. In other words, similar to Chugai's beta indicator, it measures the risk of Chugai Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of Chugai Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.

Chugai Pharmaceutical Investment Opportunity

Chugai Pharmaceutical has a volatility of 1.72 and is 1.26 times more volatile than DOW. 14  of all equities and portfolios are less risky than Chugai Pharmaceutical. Compared to the overall equity markets, volatility of historical daily returns of Chugai Pharmaceutical is lower than 14 () of all global equities and portfolios over the last 90 days. Use Chugai Pharmaceutical to protect your portfolios against small market fluctuations. The otc stock experiences a normal downward fluctuation but is a risky buy. Check odds of Chugai Pharmaceutical to be traded at $27.29 in 90 days. . Let's try to break down what Chugai's beta means in this case. As returns on the market increase, returns on owning Chugai Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Chugai Pharmaceutical is likely to outperform the market.

Good diversification

The correlation between Chugai Pharmaceutical and DJI is Good diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Chugai Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.

Chugai Pharmaceutical Additional Risk Indicators

The analysis of Chugai Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Chugai Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of Chugai Pharmaceutical stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance(0.28)
Market Risk Adjusted Performance2.07
Mean Deviation0.8182
Coefficient Of Variation(484.44)
Standard Deviation1.68
Variance2.82
Information Ratio(0.15)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Chugai Pharmaceutical Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Walker Dunlop vs. Chugai Pharmaceutical
Vmware vs. Chugai Pharmaceutical
COSCO SHIPPING vs. Chugai Pharmaceutical
BANK OF NINGBO vs. Chugai Pharmaceutical
Meta Platforms vs. Chugai Pharmaceutical
Microsoft Corp vs. Chugai Pharmaceutical
HITHINK ROYALFLUSH vs. Chugai Pharmaceutical
Salesforce vs. Chugai Pharmaceutical
Ford vs. Chugai Pharmaceutical
Sentinelone Inc vs. Chugai Pharmaceutical
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Chugai Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Chugai Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Chugai Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Chugai Pharmaceutical.
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.